<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Normal range for coagulation tests by age</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Normal range for coagulation tests by age</h1>
<div class="graphic"><div class="figure"><div class="ttl">Normal range for coagulation tests by age</div><div class="cntnt"><table cellspacing="0"><colgroup span="8" width="12%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Coagulation tests</td> <td class="subtitle1" colspan="7">Age</td> </tr> <tr> <td class="subtitle2"> <p>Day 1 of life</p> <p>Mean (boundary)</p> </td> <td class="subtitle2"> <p>Day 3 of life</p> <p>Mean (boundary)</p> </td> <td class="subtitle2"> <p>1 to 12 months</p> <p>Mean (boundary)</p> </td> <td class="subtitle2"> <p>1 to 5 years</p> <p>Mean (boundary)</p> </td> <td class="subtitle2"> <p>6 to 10 years</p> <p>Mean (boundary)</p> </td> <td class="subtitle2"> <p>11 to 16 years</p> <p>Mean (boundary)</p> </td> <td class="subtitle2"> <p>Adult</p> <p>Mean (boundary)</p> </td> </tr> <tr> <td>PT(s)*</td> <td>15.6 (14.4-16.4)<sup>¶</sup></td> <td>14.9 (13.5-16.4)<sup>¶</sup></td> <td>13.1 (11.5-15.3)</td> <td>13.3 (12.1-14.5)<sup>¶</sup></td> <td>13.4 (11.7-15.1)<sup>¶</sup></td> <td>13.8 (12.7-16.1)<sup>¶</sup></td> <td>13 (11.5-14.5)</td> </tr> <tr> <td>INR</td> <td>1.26 (1.15-1.35)<sup>¶</sup></td> <td>1.2 (1.05-1.35)<sup>¶</sup></td> <td>1 (0.86-1.22)</td> <td>1.03 (0.92-1.14)<sup>¶</sup></td> <td>1.04 (0.87-1.2)<sup>¶</sup></td> <td>1.08 (0.97-1.3)<sup>¶</sup></td> <td>1 (0.8-1.2)</td> </tr> <tr> <td>aPTT(s)*</td> <td>38.7 (34.3-44.8)<sup>¶</sup></td> <td>36.3 (29.5-42.2)<sup>¶</sup></td> <td>39.3 (35.1-46.3)<sup>¶</sup></td> <td>37.7 (33.6-46.3)<sup>¶</sup></td> <td>37.3 (31.8-43.7)<sup>¶</sup></td> <td>39.5 (33.9-46.1)<sup>¶</sup></td> <td>33.2 (28.6-38.2)</td> </tr> <tr> <td>Fibrinogen (g/L)</td> <td>2.8 (1.92-3.74)</td> <td>3.3 (2.83-4.01)</td> <td>2.42 (0.82-3.83)<sup>¶</sup></td> <td>2.82 (1.62-4.01)<sup>¶</sup></td> <td>3.04 (1.99-4.09)</td> <td>3.15 (2.12-4.33)</td> <td>3.1 (1.9-4.3)</td> </tr> <tr> <td>Factor II (U/mL)</td> <td>0.54 (0.41-0.69)<sup>¶</sup></td> <td>0.62 (0.5-0.73)<sup>¶</sup></td> <td>0.9 (0.62-1.03)<sup>¶</sup></td> <td>0.89 (0.7-1.09)<sup>¶</sup></td> <td>0.89 (0.67-1.1)<sup>¶</sup></td> <td>0.9 (0.61-1.07)<sup>¶</sup></td> <td>1.1 (0.78-1.38)</td> </tr> <tr> <td>Factor V (U/mL)</td> <td>0.81 (0.64-1.03)<sup>¶</sup></td> <td>1.22 (0.92-1.54)</td> <td>1.13 (0.94-1.41)</td> <td>0.97 (0.67-1.27)<sup>¶</sup></td> <td>0.99 (0.56-1.41)<sup>¶</sup></td> <td>0.89 (0.67-1.41)<sup>¶</sup></td> <td>1.18 (0.78-1.52)</td> </tr> <tr> <td>Factor VII (U/mL)</td> <td>0.7 (0.52-0.88)<sup>¶</sup></td> <td>0.86 (0.67-1.07)<sup>¶</sup></td> <td>1.28 (0.83-1.6)</td> <td>1.11 (0.72-1.5)<sup>¶</sup></td> <td>1.13 (0.7-1.56)<sup>¶</sup></td> <td>1.18 (0.69-2)</td> <td>1.29 (0.61-1.99)</td> </tr> <tr> <td>Factor VIII (U/mL)</td> <td>1.82 (1.05-3.29)</td> <td>1.59 (0.83-2.74)</td> <td>0.94 (0.54-1.45)<sup>¶</sup></td> <td>1.1 (0.36-1.85)<sup>¶</sup></td> <td>1.17 (0.52-1.82)<sup>¶</sup></td> <td>1.2 (0.59-2)<sup>¶</sup></td> <td>1.6 (0.52-2.9)</td> </tr> <tr> <td>vWF (U/mL)</td> <td>n/a</td> <td>n/a</td> <td>n/a</td> <td>0.82 (0.6-1.2)</td> <td>0.95 (0.44-1.44)</td> <td>1 (0.46-1.53)</td> <td>0.92 (0.5-1.58)</td> </tr> <tr> <td>Factor IX (U/mL)</td> <td>0.48 (0.35-0.56)<sup>¶</sup></td> <td>0.72 (0.44-0.97)<sup>¶</sup></td> <td>0.71 (0.43-1.21)<sup>¶</sup></td> <td>0.85 (0.44-1.27)<sup>¶</sup></td> <td>0.96 (0.48-1.45)<sup>¶</sup></td> <td>1.11 (0.64-2.16)<sup>¶</sup></td> <td>1.3 (0.59-2.54)</td> </tr> <tr> <td>Factor X (U/mL)</td> <td>0.55 (0.46-0.67)<sup>¶</sup></td> <td>0.6 (0.46-0.75)<sup>¶</sup></td> <td>0.95 (0.77-1.22)<sup>¶</sup></td> <td>0.98 (0.72-1.25)<sup>¶</sup></td> <td>0.97 (0.68-1.25)<sup>¶</sup></td> <td>0.91 (0.53-1.22)<sup>¶</sup></td> <td>1.24 (0.96-1.71)</td> </tr> <tr> <td>Factor XI (U/mL)</td> <td>0.3 (0.7-0.41)<sup>¶</sup></td> <td>0.57 (0.24-0.79)<sup>¶</sup></td> <td>0.89 (0.62-1.25)<sup>¶</sup></td> <td>1.13 (0.65-1.62)</td> <td>1.13 (0.65-1.62)</td> <td>1.11 (0.65-1.39)</td> <td>1.12 (0.67-1.96)</td> </tr> <tr> <td>Factor XII (U/mL)</td> <td>0.58 (0.43-0.8)<sup>¶</sup></td> <td>0.53 (0.14-0.8)<sup>¶</sup></td> <td>0.79 (0.2-1.35)<sup>¶</sup></td> <td>0.85 (0.36-1.35)<sup>¶</sup></td> <td>0.81 (0.26-1.37)<sup>¶</sup></td> <td>0.75 (0.14-1.17)<sup>¶</sup></td> <td>1.15 (0.35-2.07)</td> </tr> <tr> <td>XIIIa (U/mL)</td> <td>n/a</td> <td>n/a</td> <td>n/a</td> <td>1.08 (0.72-1.43)<sup>¶</sup></td> <td>1.09 (0.65-1.51)<sup>¶</sup></td> <td>0.99 (0.57-1.4)</td> <td>1.05 (0.55-1.55)</td> </tr> <tr> <td>XIIIs (U/mL)</td> <td>n/a</td> <td>n/a</td> <td>n/a</td> <td>1.13 (0.69-1.56)<sup>¶</sup></td> <td>1.16 (0.77-1.54)<sup>¶</sup></td> <td>1.02 (0.6-1.43)</td> <td>0.97 (0.57-1.37)</td> </tr> </tbody></table></div><div class="graphic_lgnd">All factors except fibrinogen are expressed as units per milliliter, where pooled plasma contains 1.0 U/mL. All data are expressed as the mean, followed by the upper and lower boundary encompassing 95% of the population. Between 20 and 67 samples were assayed for each value for each age group. Some measurements were skewed due to a disproportionate number of high values. The lower limit, which excludes the lower 2.5% of the population, is given.</div><div class="graphic_footnotes">PT: prothrombin time; INR: international normalized ratio; aPTT: activated partial thromboplastin time; VIII: factor VIII procoagulant; vWF: von Willebrand factor; n/a: data not available.<br/>* Normal range for PT and aPTT should be based upon the standards set by individual clinical laboratories.<br/>¶ Denotes values that are significantly different from adults.</div><div class="graphic_reference">Data on vWF, XIIIa and XIIIs from: Andrew M, Vegh P, Johnston M, et al. Maturation of the Hemostatic System During Childhood. Blood 1992; 80:1999.<br/>Remaining data from: Monagle P, Barnes C, Ignjatovic V, et al. Developmental Haemostasis. Thrombosis and Haemostasis 2006; 95:362.</div><div id="graphicVersion">Graphic 66999 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
